The neurological mutant quakingviable is Parkin deficient

Mammalian Genome

Volumn 15, Issue 3, 2004, Pages 210-217

  Lorenzetti, Diego ^a   Antalffy, Barbara ^a   Vogel, Hannes ^b   Noveroske, Janice ^c   Armstrong, Dawna ^a   Justice, Monica ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; GENE PRODUCT; PARKIN; PROTEIN; QUAKING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL FUNCTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; UBIQUITINATION;

ALPHA-SYNUCLEIN; ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA FINGERPRINTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, QUAKING; NERVE TISSUE PROTEINS; PRECIPITIN TESTS; PROTEINS; SUBSTANTIA NIGRA; SYNUCLEINS; UBIQUITIN-PROTEIN LIGASES;

ANIMALIA;

EID: 1442359885     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-003-2333-5     Document Type: Article

References (32)

1. Cai WW, Reneker J, Chow CW, Vaishnav M, Bradley A (1998) An anchored framework BAC map of mouse chromosome 11 assembled using multiplex oligonucleotide hybridization. Genomics 54, 387-397
2. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, et al. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewybody formation in Parkinson disease. Nat Med 7, 1144-1150
3. Corti O, Hampe C, Koutnikova H, Darios F, Jacquier S, et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet 12, 1427-1437
4. Cox RD, Shedlovsky A, Hamvas R, Goldsworthy M, Whittington J, et al. (1994) A 1.2-Mb YAC contig spans the quaking region. Genomics 21, 77-84
5. Cox RD, Hugill A, Shedlovsky A, Noveroske JK, Best S, et al. (1999) Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics 57, 333-341
6. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, et al. (2003) Parkin prevents mitochondrial swelling and cytochrome C release in mitochondria- dependent cell death. Hum Mol Genet 12, 517-526
7. viable. Genetics 131, 183-190
8. Ebersole TA, Chen Q, Justice MJ, Artzt K (1996) The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet 12, 260-265
9. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278, 43628-43635
10. viable mutant mice. J Neurosci 16, 7941-7949
11. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, et al. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902
12. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12, 2277-2291
13. Justice MJ, Bode VC (1988) Three ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations. Genet Res 51, 95-102
14. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608
15. Lee MK, Stirling W, Xu Y, Xu X, Qui D, et al. (2002) Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99, 8968-8973
16. Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, et al. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269
17. Matsumine H, Saito M, Shimoda-Matsubayashi S, Tanaka H, Ishikawa A, et al. (1997) Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 60, 588-596
18. Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, et al. (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8, 535-539
19. Nikulina EM, Skrinskaya JA, Avgustinovich DF, Popova NK (1995) Dopaminergic brain system in the quaking mutant mouse. Pharmacol Biochem Behav 50, 333-337
20. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047
21. Ren Y, Zhao J, Feng J (2003) Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci 23, 3316-3324
22. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, et al. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25, 302-305
23. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, et al. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269
24. Sidman RL, Dickie MM, Appel SH (1964) Mutant mice (Quaking and Jimpy) with deficient myelination in central nervous system. Science 144, 309-311
25. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840
26. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95, 6469-6473
27. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, et al. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749
28. Stichel CC, Augustin M, Kuhn K, Zhu XR, Engels P, et al. (2000) Parkin expression in the adult mouse brain. Eur J Neurosci 12, 4181-4194
29. Takahashi H, Ohama E, Suzuki S, Horikawa Y, Ishikawa A, et al. (1994) Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44,437-441
30. West AB, Lockhart PJ, O'Farell C, Farrer MJ (2003). Identification of a novel gene linked to parkin via a bidirectional promoter. J Mol Biol 326, 11-19
31. Winston JT, Chu C, Harper JW (1999) Culprits in the degradation of cyclin E apprehended. Genes Dev 13, 2751-2757
32. Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, et al. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97, 13354-13359